Biora Therapeutics, Inc. (BIOR)
NASDAQ: BIOR · Real-Time Price · USD
2.950
-0.380 (-11.41%)
At close: Nov 4, 2024, 4:00 PM
2.990
+0.040 (1.35%)
After-hours: Nov 4, 2024, 7:38 PM EST
Biora Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 11 | 37 | 29 | 374 | 296 | - | |
| Market Cap Growth | -53.99% | 24.98% | -92.14% | 26.17% | - | - | |
| Enterprise Value | 54 | 108 | 123 | 477 | 310 | - | |
| Last Close Price | 2.95 | 13.50 | 32.92 | 522.50 | 1327.50 | - | |
| PE Ratio | - | -0.17 | -0.66 | -0.81 | -0.76 | - | |
| PS Ratio | 8.98 | 9183.13 | 96.37 | 299.75 | 1828.75 | - | |
| PB Ratio | -0.27 | -0.36 | -0.29 | -4.40 | -2.77 | - | |
| P/FCF Ratio | -0.49 | -0.76 | -0.45 | -2.22 | -1.75 | - | |
| P/OCF Ratio | -0.49 | -0.76 | -0.46 | -2.23 | -1.79 | - | |
| EV/Sales Ratio | 62.99 | 26878.38 | 404.76 | 382.91 | 1910.59 | - | |
| EV/EBITDA Ratio | -0.89 | -1.61 | -2.03 | -4.10 | -2.91 | - | |
| EV/EBIT Ratio | -0.89 | -1.60 | -2.00 | -4.05 | -2.88 | - | |
| EV/FCF Ratio | -1.24 | -2.21 | -1.89 | -2.84 | -1.82 | - | |
| Debt / Equity Ratio | -0.54 | -0.47 | -1.27 | -1.49 | -1.52 | -0.87 | |
| Debt / FCF Ratio | -1.00 | -0.98 | -1.99 | -0.75 | -0.96 | -0.67 | |
| Asset Turnover | 0.03 | 0.00 | 0.00 | 0.01 | 0.00 | 1.32 | |
| Inventory Turnover | - | - | - | - | - | 10.83 | |
| Quick Ratio | 0.13 | 0.25 | 1.34 | 1.45 | 1.36 | 0.56 | |
| Current Ratio | 0.20 | 0.30 | 1.64 | 1.60 | 1.74 | 0.74 | |
| Return on Assets (ROA) | -125.06% | -99.04% | -47.56% | -55.95% | -52.51% | -80.30% | |
| Return on Capital (ROIC) | - | - | -111.31% | -151.02% | -298.17% | -693.16% | |
| Earnings Yield | -798.13% | -337.89% | -129.82% | -66.19% | -64.99% | - | |
| FCF Yield | -446.93% | -132.31% | -221.86% | -45.04% | -57.25% | - | |
| Buyback Yield / Dilution | -166.52% | -106.59% | -98.51% | -249.49% | -463.47% | -4.84% | |
| Total Shareholder Return | -166.52% | -106.59% | -98.51% | -249.49% | -463.47% | -4.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.